Change in Funding Opportunity Announcements That Use R03, R21, R33, and R34 Grant Mechanisms: Transition to Electronic Submission Using SF424 (R&R) Grant Application Package


Notice Number: NOT-OD-06-046

Key Dates
Release Date: March 2, 2006

Issued by
National Institutes of Health (NIH), (http://www.nih.gov/)
Agency for Healthcare Research and Quality (AHRQ), (http://www.ahrq.gov/)
Centers for Disease Control and Prevention (CDC), (http://www.cdc.gov/)

The purpose of this Notice is to announce the following changes regarding funding opportunity announcements (FOAs) that utilize the Small Research Grant (R03), Exploratory/Developmental Research Grant (R21), the Phased Innovation Award (R21/R33), and the NIH Clinical Trial Planning Grant (R34) mechanisms

Effective June 1, 2006, R03 and R21 paper applications will no longer be accepted by the NIH, AHRQ or CDC. See http://grants.nih.gov/grants/guide/notice-files/NOT-OD-05-067.html. We are transitioning to electronic submission on the SF424 Research and Research Related (R&R) application form through Grants.gov by mechanism, which requires that we expire and/or issue separate FOAs for each mechanism to accommodate the new process. The use of “parent” FOAs will provide a means for standardizing the R03 and R21 application characteristics, requirements, preparation, and review procedures. These parent announcements accommodate investigator-initiated (unsolicited) applications and allow Institutes/Centers (ICs)/Agencies to describe how they use each mechanism and highlight their specific areas of scientific interest within a single FOA. Note, currently, there is not a Parent R34 FOA; each IC plans to issue separate R34 announcements.

The FOAs identified below are grouped in three categories according to the current plan of action. Any changes from the current plan will be reflected on individual FOAs.

  1. Those that will expire effective March 2, 2006.
  2. Those for which the Parent R03 and Parent R21 FOAs now include the scientific opportunities from currently published FOAs. Note: There will not be a Parent R34. Each IC will issue separate R34 announcements.
  3. Those that will be reissued on or after March 2, 2006.

Where noted, R01 and other mechanisms that have not transitioned to electronic grant submission will continue to be accepted by the NIH in response to the FOAs shown below, but applicants MUST use the PHS 398 application in paper format until the mechanism transitions to the SF424 (R&R) electronic format. See http://era.nih.gov/ElectronicReceipt/files/timeline_adjustments_to_r01.htm. Specifically, R01 applications must be submitted electronically effective February 1, 2007 for new applications and March 1, 2007 for resubmission, competing renewal, and supplemental applications. The current schedule and other important information related to NIH’s transition from the PHS398 paper application to the SF424 (R&R) electronic application is available at: http://era.nih.gov/ElectronicReceipt/.

Over time, NIH will transition all funding mechanisms to the SF424 (R&R) form and electronic submission through Grants.gov. For now we are seeking to bring individual mechanisms into this new unified process in a measured way to ensure that the NIH can accept the applications without difficulty and that institutions/organizations have time to experience the new electronic ways of doing business.

1. FOAs that expire effective March 2, 2006.

Applicants interested in submitting investigator-initiated research projects in the following scientific areas are encouraged to contact IC program staff identified in the FOA number below.

FOA Number

Mechanism

Title

PA-03-079

R01, R21

EMERGING TECHNOLOGIES FOR THE STUDY OF REPRODUCTIVE NEUROENDOCRINOLOGY

PA-03-100

R21

NIGMS EXPLORATORY STUDIES FOR HIGH IMPACT/HIGH RISK RESEARCH

PA-03-163

R01, R03

NUTRITION AND THE DEVELOPMENT, TREATMENT, AND PREVENTION OF HIV DISEASE IN WOMEN, INFANTS, AND CHILDREN

PA-04-056

R01, R03

ENDOMETRIAL CELL FUNCTION

PA-05-001

R01, R21, P01

METALS IN MEDICINE
Note: Only expiring for R03/R21. The R01 and P01 mechanisms will continue to be accepted using paper PHS 398 application.

PA-05-075

R01, R21

NEUROLOGIC MOTOR SPEECH DISORDERS AND SPEECH MOTOR CONTROL
Note: Only expiring for R03/R21. The R01 mechanism will continue to be accepted using paper PHS 398 application.

PAR-03-019

R03

NEI SMALL RESEARCH GRANTS FOR DATA ANALYSIS (R03)

PAS-03-081

R01, R21

ALTERNATIVE TEST MODELS FOR ASSESSING GENITAL IRRITATION OF MICROBICIDAL/SPERMICIDAL PRODUCTS

PAS-03-122

R01, R21

FRAILTY IN OLD AGE: PATHOPHYSIOLOGY AND INTERVENTIONS

PAS-03-165

R01, R21

NEUROPROTECTIVE CNS BARRIERS IN NEUROLOGICAL DISEASES

PAS-03-168

R01, R03

ENROLLING WOMEN AND MINORITIES IN HIV/AIDS RESEARCH TRIALS

2. The following FOAs are now part of the Parent R03 and Parent R21.
Note: Applicants interested in the specific opportunities listed below must apply electronically using the application package from the Parent R03 or Parent R21.
(R01 and P01 applications will continue to be accepted using the paper PHS 398.)

FOA Number

Mechanism

Title

PA-03-015

R21

NHLBI INNOVATIVE RESEARCH GRANT PROGRAM

PA-03-058

R21

EXPLORATORY/DEVELOPMENTAL (R21) BIOENGINEERING RESEARCH GRANTS (EBRG)

PA-03-061

R01, R03, R21

EPIDEMIOLOGY OF ALCOHOL CONSUMPTION AND ALCOHOL-RELATED PROBLEMS IN OLDER PERSONS

PA-03-088

R01, R21, R03

TREATMENT OF ADOLESCENTS WITH ALCOHOL USE DISORDERS

PA-03-107

R21

NIH EXPLORATORY/DEVELOPMENTAL RESEARCH GRANT AWARD

PA-03-108

R03

NIH SMALL RESEARCH GRANT PROGRAM

PA-03-111

R01, R03, R21

RESEARCH ON ADHERENCE TO INTERVENTIONS FOR MENTAL DISORDERS

PA-03-113

R01, R03, R21

DEVELOPMENTAL PSYCHOPHARMACOLOGY

PA-03-132

R21

SECONDARY ANALYSIS OF EXISTING ALCOHOL AND HIV/AIDS DATA SETS

PA-03-141

R01, R21

GENE-ENVIRONMENT INTERACTIONS INFLUENCING ALCOHOL-RELATED PHENOTYPES AND DISEASES

PA-03-144

R01, R03, R21

RESEARCH ON COMMUNITY REINTEGRATION FOR PEOPLE WITH PSYCHIATRIC DISABILITIES

PA-03-161

R01, R03, R21, R34

RESEARCH ON THE REDUCTION AND PREVENTION OF SUICIDALITY

PA-03-162

R01, R21

FINDING GENES FOR ALCOHOL-RELATED BEHAVIORS AND RISK FOR ALCOHOLISM

PA-03-169

R01, R03

BASIC AND TRANSLATIONAL RESEARCH IN EMOTION

PA-03-171

R21

EXPLORATORY AND DEVELOPMENTAL RESEARCH GRANTS FOR INVESTIGATIONS IN RARE DISEASES

PA-04-005

R01, R21

MECHANISMS OF ALCOHOLIC PANCREATITIS

PA-04-019

R01, R03, R34

EFFECTIVENESS, PRACTICE, AND IMPLEMENTATION IN CMHS’ CHILDREN’S SERVICE SITES

PA-04-024

R01, R03, R21

HIV/AIDS, SEVERE MENTAL ILLNESS AND HOMELESSNESS

PA-04-044

R01, R03, R21, R34

RESEARCH ON PSYCHOPATHOLOGY IN INTELLECTUAL DISABILITIES (MENTAL RETARDATION)

PA-04-048

R01, R03, R21

ALCOHOL ABUSE AND HIV/AIDS IN RESOURCE-POOR SOCIETIES

PA-04-051

R03

ELSI SMALL GRANT RESEARCH PROGRAM (R03)

PA-04-061

R01, R03, R21

RESEARCH ON RURAL MENTAL HEALTH AND DRUG ABUSE DISORDERS

PA-04-067

R01, R03, R21

PHARMACOTHERAPY FOR COMORBID ALCOHOL AND DRUG USE DISORDERS

PA-04-119

P01, R01, R21

BIODEFENSE AND EMERGING INFECTIOUS DISEASE RESEARCH OPPORTUNITIES

PA-04-150

R01, R34

DESIGN, MEASUREMENT AND STATISTICS IN COMMUNITY MH RESEARCH

PA-04-154

R01, R21

HIV INFECTION OF THE CENTRAL NERVOUS SYSTEM

PA-05-007

R01, R03, R21

CO-OCCURRING MENTAL ILLNESS, ALCOHOL AND/OR DRUG ABUSE & MEDICAL CONDITIONS

PA-05-008

R01, R03, R34

RESEARCH ON MENTAL HEALTH ECONOMICS

PA-05-018

R01, R03, R34

RESEARCH ON CO-MORBID MENTAL AND OTHER PHYSICAL DISORDERS

PA-05-019

R01, R03, R34

HEALTH BEHAVIOR CHANGE IN PEOPLE WITH MENTAL DISORDERS

PA-05-037

R01, R03, R34

FUNCTIONAL ASSESSMENT OF PEOPLE WITH MENTAL DISORDERS

PA-05-043

R21

DIRECTED STEM CELL DIFFERENTIATION FOR CELL-BASED THERAPIES FOR HEART, LUNG, AND BLOOD, AND AGING DISEASES

PA-05-046

R01, R21

RESEARCH ON SLEEP AND SLEEP DISORDERS

PA-05-054

R01, R03, R21

FUNCTIONAL LINKS BETWEEN THE IMMUNE SYSTEM, BRAIN FUNCTION AND BEHAVIOR

PA-05-074

R01, R03, R21

MECHANISMS OF ALCOHOL-INDUCED TISSUE INJURY

PA-05-088

R01, R03, R21

SECONDARY ANALYSIS OF EXISTING ALCOHOL EPIDEMIOLOGY DATA

PA-05-089

R01, R21

NUTRITION AND DIET IN THE CAUSATION, PREVENTION, AND MANAGEMENT OF HEART FAILURE

PA-05-104

R01, R03, R21, R34

TREATMENT-EMERGENT ADVERSE EFFECTS OF PSYCHOTROPIC MEDICATION

PA-05-119

R01, R03, R21

MECHANISMS OF ALCOHOLIC AND NONALCOHOLIC FATTY LIVER (STEATOSIS)

PA-05-146

R01, R03, R21

STRUCTURAL INTERVENTIONS, ALCOHOL USE, AND RISK OF HIV/AIDS

PA-05-164

R01, R03, R21

RECENT HIV INFECTION: NEW PREVENTION CHALLENGES AND OPPORTUNITIES

3. FOAs that will be reissued on or after March 2, 2006.

Note: Applicants interested in the specific opportunities listed below must apply electronically using the application package for that specific FOA. Other mechanisms (e.g., R01, P01) that have not yet transitioned to electronic submission will continue to be accepted under the existing FOAs below (e.g., PA-06-040) using the paper PHS 398 application.

FOA Number

Mechanism

Title

PA-03-065

R01, R21

CALCIUM OXALATE STONE DISEASES

PA-03-073

R01, R21

ADVANCES IN POLYCYSTIC KIDNEY DISEASE

PA-03-076

R01, R21

BASIC AND CLINICAL STUDIES OF CONGENITAL URINARY TRACT OBSTRUCTION

PA-03-091

R01, R21

ANCILLARY STUDIES OF KIDNEY DISEASE ACCESSING INFORMATION FROM CLINICAL TRIALS, EPIDEMIOLOGICAL STUDIES, AND DATABASES

PA-03-112

R21, R33

DEVELOPMENT AND APPLICATION OF PET AND SPECT LIGANDS FOR BRAIN IMAGING STUDIES (PHASED INNOVATION AWARD)

PA-03-116

R01, R21

TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) IN SEMEN

PA-03-126

R01, R03, R21

BEHAVIORAL THERAPIES DEVELOPMENT PROGRAM

PA-03-135

R01, R03, R21

WOMEN'S MENTAL HEALTH IN PREGNANCY AND THE POSTPARTUM PERIOD

PA-03-139

R01, R03, R21

WOMEN, GENDER DIFFERENCES AND DRUG ABUSE

PA-03-143

R01, R03, R21, R34

WOMEN'S MENTAL HEALTH AND SEX/GENDER DIFFERENCES RESEARCH

PA-03-145

R01, R21

UBIQUITIN AND UBIQUITIN-LIKE MODIFICATIONS REGULATING DISEASE PROCESSES

PA-03-150

R01, R21

ERYTHROID LINEAGE MOLECULAR TOOLBOX

PA-03-151

R21

PROTEOMICS IN AUDITORY DEVELOPMENTAL AND DISEASE PROCESSES

PA-03-152

R01, R21

BIOBEHAVIORAL PAIN RESEARCH

PA-03-156

R01, R21

INSULIN SIGNALING AND RECEPTOR CROSS-TALK

PA-03-159

R01, R21

CHRONIC ILLNESS SELF-MANAGEMENT IN CHILDREN

PA-03-167

R01, R21

AGING MUSCULOSKELETAL AND SKIN EXTRACELLULAR MATRIX

PA-03-170

R01, R21

HEALTH PROMOTION AMONG RACIAL AND ETHNIC MINORITY MALES

PA-04-006

R01, R21

NEUROTECHNOLOGY RESEARCH, DEVELOPMENT, AND ENHANCEMENT

PA-04-007

R01, R03, R21

DRUG ABUSE ASPECTS OF HIV/AIDS AND OTHER INFECTIONS

PA-04-012

R01, R21

CANCER SURVEILLANCE USING HEALTH CLAIMS-BASED DATA SYSTEM

PA-04-017

R01, R21

STUDIES OF THE ECONOMICS OF CANCER PREVENTION, SCREENING, AND CARE

PA-04-021

R03

SMALL GRANTS IN OCCUPATIONAL SAFETY AND HEALTH RESEARCH (R03)

PA-04-027

R01, R21

REDUCING PRETERM & LOW BIRTH WEIGHT IN MINORITY FAMILIES

PA-04-030

R21

NIOSH EXPLORATORY/DEVELOPMENTAL GRANT PROGRAM (R21)

PA-04-033

R01, R21

DIET COMPOSITION AND ENERGY BALANCE

PA-04-034

R21

EXPLORATORY GRANTS FOR BEHAVIORAL RESEARCH IN CANCER CONTROL

PA-04-035

R21

CIRCULATING CELLS IN CANCER DETECTION

PA-04-043

R01, R21

RESEARCH GRANTS FOR STUDIES OF HEPATITIS C IN THE SETTING OF RENAL DISEASE

PA-04-045

R21

IN VIVO CANCER IMAGING EXPLORATORY/DEVELOPMENTAL GRANTS

PA-04-049

R01, R03, R21

REPRODUCTIVE GENETICS AND EPIGENETICS

PA-04-053

R21

DEVELOPMENTAL PROJECTS IN COMPLEMENTARY APPROACHES TO CANCER CARE

PA-04-057

R01, R21

IMPROVING CARE FOR DYING CHILDREN AND THEIR FAMILIES

PA-04-074

R01, R21

HEALTH DISPARITIES IN NIDDK DISEASES

PA-04-075

R01, R03, R21, R34

MENTAL HEALTH CONSEQUENCES OF VIOLENCE AND TRAUMA

PA-04-081

R01, R21

PROTEOMICS: DIABETES, OBESITY, AND ENDOCRINE, DIGESTIVE, KIDNEY, UROLOGIC, AND HEMATOLOGIC DISEASES

PA-04-084

R01, R03

PSYCHOPHARMACOLOGY OF WIDELY AVAILABLE PSYCHOACTIVE NATURAL PRODUCTS

PA-04-085

R01, R03, R21

RESEARCH ON AUTISM AND AUTISM SPECTRUM DISORDERS

PA-04-088

R01, R21

NON-INVASIVE METHODS FOR DIAGNOSIS AND PROGRESSION OF DIABETES, KIDNEY, UROLOGICAL, HEMATOLOGICAL AND DIGESTIVE DISEASES

PA-04-092

R01, R21

LONG-TERM WEIGHT MAINTENANCE: BASIC AND CLINICAL STUDIES

PA-04-093

R01, R21

NOVEL APPROACHES TO STUDY POLYMICROBIAL DISEASES

PA-04-095

R21, R33

NOVEL TECHNOLOGIES FOR IN VIVO IMAGING (R21/R33)

PA-04-098

R01, R21

HETEROGENEITY OF FAT DEPOTS: UNDERLYING BASIS AND ASSOCIATION WITH MORBIDITY

PA-04-099

R01, R03, R21

DIET, EPIGENETIC EVENTS, AND CANCER PREVENTION

PA-04-100

R01, R03, R21

EPIDEMIOLOGY OF DRUG ABUSE

PA-04-101

R01, R21

CHARACTERIZATION, BEHAVIOR AND PLASTICITY OF PLURIPOTENT STEM CELLS

PA-04-102

R21, R33

PHASED APPLICATION AWARDS IN CANCER PROGNOSIS AND PREDICTION

PA-04-103

R01, R21

TESTING TOBACCO PRODUCTS PROMOTED TO REDUCE HARM

PA-04-108

R21

INNOVATIVE AND EXPLORATORY RESEARCH IN DIGESTIVE DISEASES AND NUTRITION

PA-04-109

R01, R03, R21

CROSS-DISCIPLINARY TRANSLATIONAL RESEARCH AT NIH

PA-04-110

R01, R03, R21

PRESCRIPTION DRUG ABUSE

PA-04-113

R01, R03

THE SCIENCE AND ECOLOGY OF EARLY DEVELOPMENT (SEED)

PA-04-114

R01, R03, R21

EXFOLIATED CELLS, BIOACTIVE FOOD COMPONENTS, AND CANCER

PA-04-115

R01, R21

RELIGIOUS ORGANIZATIONS AND HIV

PA-04-118

R01, R21

CELL LINEAGE AND DEVELOPMENTAL STUDIES IN HEARING AND BALANCE

PA-04-121

R01, R21

UNDERSTANDING MECHANISMS OF HEALTH RISK BEHAVIOR CHANGE IN CHILDREN AND ADOLESCENTS

PA-04-123

R03

SOCIOBEHAVIORAL DATA ANALYSIS AND ARCHIVING IN AGING

PA-04-124

P01, P30, R01, R21, U01

STUDIES OF ENERGY BALANCE AND CANCER IN HUMANS

PA-04-125

R01, R21

NOVEL APPROACHES TO ENHANCE ANIMAL STEM CELL RESEARCH

PA-04-134

R21

PILOT STUDIES: ORAL COMPLICATIONS OF CANCER THERAPIES

PA-04-137

R21

EXPLORATORY GRANT PROGRAM IN DIABETES ENDOCRINOLOGY AND METABOLISM

PA-04-139

R21

JOINT DEGENERATION: MOUSE MODELS

PA-04-144

R21

PILOT AND FEASIBILITY PROGRAM IN HEMATOLOGIC DISEASES

PA-04-145

R01, R03, R21

SCHOOL-BASED INTERVENTIONS TO PREVENT OBESITY

PA-04-146

R21

PILOT AND FEASIBILITY PROGRAM IN UROLOGY

PA-04-152

R01, R03, R21

MDMA: RESEARCH AREAS NEEDING MORE EMPHASIS

PA-04-153

R01, R21

HEALTH DISPARITIES AMONG MINORITY AND UNDERSERVED WOMEN

PA-04-157

R01,R21

RESEARCH ON MALIGNANCIES IN AIDS AND ACQUIRED IMMUNE SUPPRESSION

PA-04-158

R01, R03, R21

ANCILLARY STUDIES TO THE AD NEUROIMAGING INITIATIVE

PA-05-004

R01, R21

SYMPTOM CLUSTERS IN CANCER AND IMMUNE DISORDERS

PA-05-006

R03, R21

THE EFFECT OF RACIAL AND ETHNIC DISCRIMINATION/BIAS ON HEALTH CARE DELIVERY

PA-05-009

R01, R21

RESEARCH ON THE ECONOMICS OF DIET, ACTIVITY, AND ENERGY BALANCE

PA-05-016

R01, R21

DECISION MAKING IN HEALTH: BEHAVIOR MAINTENANCE

PA-05-017

R01, R21

DECISION MAKING IN CANCER: SINGLE-EVENT DECISIONS

PA-05-030

R01, R03, R21

CHRONIC FATIGUE SYNDROME: PATHOPHYSIOLOGY AND TREATMENT

PA-05-033

R01, R03, R21

MEN'S HETEROSEXUAL BEHAVIOR AND HIV INFECTION

PA-05-035

R01, R21

PROBIOTICS FOR PEDIATRIC ILLNESSES

PA-05-036

P01, R01, R03, R21

RETIREMENT ECONOMICS

PA-05-038

R01, R21

MUSCULAR DYSTROPHY: PATHOGENESIS AND THERAPIES

PA-05-045

R01, R21

MECHANISMS OF ADVERSE DRUG EFFECTS IN CHILDREN

PA-05-048

R01, R21

PROTEIN BIOMARKERS OF INFECTION-ASSOCIATED CANCERS

PA-05-059

R01, R21

IN UTERO EXPOSURE TO BIOACTIVE FOOD COMPONENTS AND MAMMARY CANCER RISK

PA-05-062

R01, R21

CORRELATIVE STUDIES WITH SPECIMENS FROM MULTI-SITE TRIALS

PA-05-086

R01, R21

STEM CELLS AND CANCER

PA-05-090

R01, R03, R21

METHODOLOGY AND MEASUREMENT IN THE BEHAVIORAL AND SOCIAL SCIENCES

PA-05-093

R01, R03

SECONDARY DATA ANALYSES BASED ON THE NICHD STUDY OF EARLY CHILD CARE AND YOUTH DEVELOPMENT

PA-05-094

R21

SECONDARY ANALYSES IN OBESITY, DIABETES, DIGESTIVE AND KIDNEY DISEASES

PA-05-095

R01, R21

COLLABORATIVE AWARDS IN EPILEPSY RESEARCH FOR JUNIOR INVESTIGATORS

PA-05-096

R01, R03, R21

MECHANISMS OF TRANSMISSION AND DISSEMINATION OF TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES (TSES)

PA-05-097

R01, R03, R21

COMPLEMENTARY AND ALTERNATIVE MEDICINE FOR SUBSTANCE AND ALCOHOL RELATED DISORDERS

PA-05-098

R01, R21

DEVELOPMENT OF DISEASE BIOMARKERS

PA-05-099

R01, R03, R21

INHALANT ABUSE: SUPPORTING BROAD-BASED RESEARCH APPROACHES

PA-05-103

R21

PILOT AND FEASIBILITY PROGRAM RELATED TO THE KIDNEY

PA-05-108

R01, R03, R21

SHARED NEUROBIOLOGY OF FRAGILE X SYNDROME AND AUTISM

PA-05-111

R01, R03, R21

ECONOMICS OF PREVENTION AND TREATMENT SERVICES FOR DRUG AND ALCOHOL ABUSE

PA-05-116

R03, R21

PILOT STUDIES IN PANCREATIC CANCER

PA-05-118

R01, R03, R21

DRUG ABUSE PREVENTION INTERVENTION RESEARCH

PA-05-125

R01, R21

DIET-INDUCED CHANGES IN INFLAMMATION AS DETERMINANTS OF COLON CANCER

PA-05-136

R01, R21

TESTING STEM CELL THERAPY IN MOUSE MODELS OF PREMATURE AGING

PA-05-137

R01, R21

ETIOLOGY, PREVENTION, AND TREATMENT OF HEPATOCELLULAR CARCINOMA (R01 AND R21)

PA-05-139

R01, R03, R21

HEALTH SERVICES RESEARCH ON THE PREVENTION AND TREATMENT OF DRUG AND ALCOHOL ABUSE

PA-05-141

R01, R15, R21

TITLE: BASIC AND PRECLINICAL RESEARCH ON COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM)

PA-05-142

R01, R21

BIOBEHAVIORAL METHODS TO IMPROVE OUTCOMES RESEARCH

PA-05-154

R01, R21

STRUCTURAL ANALYSES OF THE LIGAND-BINDING PROPERTIES OF TASTE AND SMELL RECEPTORS

PA-05-155

R01, R21

THE SECRETORY PATTERN OF SENESCENT CELLS

PA-05-162

R01, R03, R21, R34

NEURODEVELOPMENT AND NEUROENDOCRINE SIGNALING IN ADOLESCENCE: RELEVANCE TO MENTAL HEALTH

PA-05-165

R21

EXPLORATORY STUDIES IN CANCER DETECTION, DIAGNOSIS, AND PROGNOSIS

PA-06-040

R01, R21

NIDCD PATIENT-ORIENTED RESEARCH GRANT

PA-06-082

R03

RESEARCH ON SOCIAL WORK PRACTICE AND CONCEPTS IN HEALTH (R03)

PA-06-083

R21

RESEARCH ON SOCIAL WORK PRACTICE AND CONCEPTS IN HEALTH (R21)

PA-06-098

R21

PARENTING CAPACITIES AND HEALTH OUTCOMES IN YOUTHS AND ADOLESCENTS (R21)

PA-06-101

R21

RESEARCH ON CLINICAL DECISION MAKING IN LIFE-THREATENING ILLNESS (R21)

PA-06-106

R03

RESEARCH ON THE COGNITIVE SEQUELAE OF PARKINSON'S DISEASE (R03)

PA-06-107

R21

RESEARCH ON THE COGNITIVE SEQUELAE OF PARKINSON'S DISEASE

PA-06-109

R21, R33

PHASED INNOVATION AWARDS IN AIDS VACCINE RESEARCH

PAR-01-040

R03

AHRQ SMALL RESEARCH GRANT PROGRAM

PAR-02-133

R03, R21

RAPID ASSESSMENT POST-IMPACT OF DISASTER

PAR-03-045

R01, R21

NANOSCIENCE AND NANOTECHNOLOGY IN BIOLOGY AND MEDICINE

PAR-03-059

R21

INTERNATIONAL COLLABORATIVE ORAL HEALTH RESEARCH PLANNING GRANT

PAR-03-078

R34

FROM INTERVENTION DEVELOPMENT TO SERVICES: EXPLORATORY RESEARCH GRANTS (R34)

PAR-03-146

R03

BEHAVIORAL SCIENCE TRACK AWARD FOR RAPID TRANSITION (B/START) – NIDA

PAR-03-153

R21

NCCAM EXPLORATORY/DEVELOPMENTAL GRANT FOR CLINICAL STUDIES (R21)

PAR-04-010

R03

BEHAVIORAL SCIENCE TRACK AWARD FOR RAPID TRANSITION (B/START)

PAR-04-062

R03

NIDCD SMALL GRANT (R03) PROGRAM

PAR-04-070

R03

SMALL GRANT PROGRAM FOR NIDDK K08/K23 RECIPIENTS

PAR-04-082

R03

SMALL CLINICAL GRANTS IN DIGESTIVE DISEASES, NUTRITION AND OBESITY

PAR-04-087

R21

GENERAL CLINICAL RESEARCH CENTER COMPLEMENTARY AND ALTERNATIVE MEDICINE RESEARCH PROGRAM

PAR-04-091

R03

NIDCR SMALL RESEARCH GRANTS FOR DATA ANALYSIS AND STATISTICAL METHODOLOGY (R03)

PAR-04-117

R03

UNDERSTANDING AND PROMOTING HEALTH LITERACY (R03)

PAR-04-133

R21

CLINICAL TRIALS: ORAL COMPLICATIONS OF CANCER THERAPY

PAR-04-138

R21

DEVELOPMENTAL INFRASTRUCTURE FOR POPULATION

PAR-04-147

R03

CANCER PREVENTION RESEARCH SMALL GRANT PROGRAM

PAR-04-155

R21

QUICK-TRIALS FOR NOVEL CANCER THERAPIES: EXPLORATORY GRANTS

PAR-04-159

R03

SMALL GRANTS PROGRAM FOR CANCER EPIDEMIOLOGY

PAR-05-020

R21

NIDCR EXPLORATORY AND DEVELOPMENTAL GRANTS IN CLINICAL RESEARCH

PAR-05-023

R01, R21

NIDCD TRANSLATIONAL RESEARCH GRANTS

PAR-05-026

R01, R21

COMMUNITY PARTICIPATION IN RESEARCH

PAR-05-057

P01, P41, P50, P60, R01, R33

CONTINUED DEVELOPMENT AND MAINTENANCE OF SOFTWARE

PAR-05-072

R03

INTERNATIONAL RESEARCH COLLABORATION – BASIC BIOMEDICAL (FIRCA-BB)

PAR-05-073

R03

INTERNATIONAL RESEARCH COLLABORATION – BEHAVIORAL, SOCIAL SCIENCES (FIRCA-BSS)

PAR-05-100

R01, R21

BRAIN DISORDERS IN THE DEVELOPING WORLD: RESEARCH ACROSS THE LIFESPAN

PAR-05-112

R34

NIAID CLINICAL TRIAL PLANNING (R34) GRANTS

PAR-05-114

R21

QUICK-TRIALS FOR IMAGING AND IMAGE-GUIDED INTERVENTIONS: EXPLORATORY GRANTS

PAR-05-150

R01, R03, R21, R34

MECHANISM FOR TIME-SENSITIVE RESEARCH OPPORTUNITIES

PAR-05-152

R21

CAM AT MINORITY OR HEALTH DISPARITIES RESEARCH CENTERS

PAR-05-157

R21

NINDS EXPLORATORY/DEVELOPMENTAL PROJECTS IN TRANSLATIONAL RESEARCH

PAR-05-168

R01, R21

INTERDISCIPLINARY PARTNERSHIPS IN ENVIRONMENTAL HEALTH SCIENCES

PAR-06-025

R21

NIDCR CLINICAL PILOT DATA GRANT

PAR-06-026

R21

NIDCR CLINICAL TRIAL PLANNING GRANT

PAR-06-043

R21

EXPLORATORY/DEVELOPMENTAL PROGRAM FOR TRANSLATIONAL RESEARCH IN MUSCULAR DYSTROPHY

PAR-06-059

R21

INNOVATIVE THERAPIES AND CLINICAL STUDIES FOR SCREENABLE DISORDERS (R21)

PAR-06-061

R03

INNOVATIVE THERAPIES AND CLINICAL STUDIES FOR SCREENABLE DISORDERS (R03)

PAR-06-071

R03

DISSEMINATION AND IMPLEMENTATION RESEARCH IN HEALTH (R03)

PAR-06-072

R21

DISSEMINATION AND IMPLEMENTATION RESEARCH IN HEALTH (R21)

PAR-06-073

R03

SMALL GRANTS FOR BEHAVIORAL RESEARCH IN CANCER CONTROL (R03)

PAR-06-075

R03

COLLABORATIVE CAM RESEARCH DEVELOPMENT CAPABILITY ENHANCEMENT GRANT AT MINORITY-SERVING INSTITUTIONS (R03)

PAR-06-092

R03

IMAGING - SCIENCE TRACK AWARD FOR RESEARCH TRANSITION (I/START) [R03]

PAR-06-111

R03

NIAMS SMALL GRANT PROGRAM FOR NEW INVESTIGATORS

PAR-06-112

R21

PILOT AND FEASIBILITY CLINICAL RESEARCH GRANTS IN KIDNEY OR UROLOGIC DISEASES

PAS-03-092

R01, R21

GENE DISCOVERY FOR COMPLEX NEUROLOGICAL AND NEUROBEHAVIORAL DISORDERS

PAS-03-173

R01, R21

NEUROBIOLOGY OF PERSISTENT PAIN MEDIATED BY THE TRIGEMINAL NERVE

PAS-04-066

R21

SIMIAN MODELS FOR THE ORAL BIOLOGY OF HIV INFECTION AND AIDS-RELATED ORAL COMPLICATIONS

PAS-04-072

R01, R21

NEUROVASCULAR MECHANISMS OF BRAIN FUNCTION AND DISEASE

PAS-04-079

R01, R21

UNDERSTANDING AND PREVENTING BRAIN TUMOR DISPERSAL

PAS-04-111

R03

NIAID INTERNATIONAL RESEARCH IN INFECTIOUS DISEASES (IRID) R03 PROGRAM

PAS-04-120

R01, R21

CNS THERAPY DEVELOPMENT FOR LYSOSOMAL STORAGE DISORDERS

PAS-04-130

R01, R21

COLLABORATIVE RESEARCH IN STEM CELL BIOLOGY

PAS-04-149

R01, R21

GENETICS AND PATHOBIOLOGY OF VASCULAR COGNITIVE IMPAIRMENT

PAS-05-002

R01, R21

AXONAL DAMAGE IN MULTIPLE SCLEROSIS: STRATEGIES FOR PROTECTION AND REPAIR

PAS-05-022

R21

R21 GRANTS FOR ALZHEIMER'S DISEASE DRUG DISCOVERY

PAS-05-024

R01, R03, R21

BASIC AND CLINICAL RESEARCH ON RETT SYNDROME AND MECP2

PAS-05-078

R01, R03, R21

NON-HUMAN LENTIVIRAL MODELS OF THE NEUROLOGICAL COMPLICATIONS OF AIDS

PAS-05-085

R01, R03, R21

UNDERSTANDING AND TREATING TUBEROUS SCLEROSIS COMPLEX

PAS-05-092

R01, R03, R21

INTERACTIONS BETWEEN STEM AND PROGENITOR CELLS AND THE MICROENVIRONMENT IN VIVO

Inquiries

Please direct inquiries regarding this notice to:

Jo Anne Goodnight
Acting Director, Office of Extramural Programs
NIH SBIR/STTR Program Coordinator
Office of Extramural Research
National Institutes of Health
Department of Health and Human Services
6705 Rockledge Drive
Rockledge I Building, Room 3534
Bethesda MD 20892
ph: 301-435-2688
fax: 301-480-0146
email: OEPmailbox@mail.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.